Skip to main content
Top
Gepubliceerd in: Quality of Life Research 11/2017

17-06-2017

Idio Scale Judgment: evaluation of a new method for estimating responder thresholds

Auteurs: Karon F. Cook, Michael A. Kallen, Cheryl D. Coon, David Victorson, Deborah M. Miller

Gepubliceerd in: Quality of Life Research | Uitgave 11/2017

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To pilot the newly developed Idio Scale Judgment method for estimating the amount of score change that matters to patients (i.e., change thresholds).

Methods

An online panel of 500 participants diagnosed with multiple sclerosis (MS) responded to the Neuro-QoL fatigue scale and to demographic and clinical questions. Participants compared their own fatigue to that represented by seven short form summaries (SFSs) that were located relatively close to their own fatigue levels. They judged these as representing the same, greater, or less fatigue than their own. We calculated the distances between patients’ own levels of fatigue and the location of SFSs they endorsed as a change that would make a difference in daily life. These distances were used as estimates of change thresholds. Logically inconsistent judgments were tabulated and associations with clinical and demographic variables were estimated.

Results

Change thresholds based on mean individual thresholds for consequential change were calculated for improvement (−3.5) and worsening (3.2). The majority of participants had no logically inconsistent judgments (69%). Having one or more reversals in judgment was not significantly associated with education or fatigue score, but was weakly associated with age, gender, and MS type and moderately associated with ratings of confidence in SFS comparisons.

Conclusions

As piloted, Idio Scale Judgment had a number of design strengths. Participants made comparisons to levels of fatigue that were within range of their own, and their judgments were contextualized in personally relevant consequences. The design lends itself to collection of data in large samples allowing evaluation of the range of judgments. Some study limitations could be mitigated with modifications. We concluded that the Idio Scale Judgment has substantial promise as a new tool for estimating change thresholds.
Literatuur
2.
go back to reference Broderick, J. E., DeWitt, E. M., Rothrock, N., Crane, P. K., & Forrest, C. B. (2013). Advances in patient-reported outcomes: The NIH PROMIS((R)) measures. EGEMS, 1, 1015.CrossRefPubMedPubMedCentral Broderick, J. E., DeWitt, E. M., Rothrock, N., Crane, P. K., & Forrest, C. B. (2013). Advances in patient-reported outcomes: The NIH PROMIS((R)) measures. EGEMS, 1, 1015.CrossRefPubMedPubMedCentral
3.
go back to reference Khullar, O. V., Rajaei, M. H., Force, S. D., Binongo, J. N., Lasanajak, Y., Robertson, S., Pickens, A., Sancheti, M. S., Lipscomb, J., Gillespie, T. W., Fernandez, F. G. (2017). Pilot study to integrate patient reported outcomes after lung cancer operations into the Society of Thoracic Surgeons Database. The Annals of Thoracic Surgery. Khullar, O. V., Rajaei, M. H., Force, S. D., Binongo, J. N., Lasanajak, Y., Robertson, S., Pickens, A., Sancheti, M. S., Lipscomb, J., Gillespie, T. W., Fernandez, F. G. (2017). Pilot study to integrate patient reported outcomes after lung cancer operations into the Society of Thoracic Surgeons Database. The Annals of Thoracic Surgery.
4.
go back to reference Betts, K. A., Griffith, J., Friedman, A., Zhou, Z. Y., Signorovitch, J. E., & Ganguli, A. (2016). An indirect comparison and cost per responder analysis of adalimumab, methotrexate and apremilast in the treatment of methotrexate-naive patients with psoriatic arthritis. Current Medical Research and Opinion, 32, 721–729.CrossRefPubMed Betts, K. A., Griffith, J., Friedman, A., Zhou, Z. Y., Signorovitch, J. E., & Ganguli, A. (2016). An indirect comparison and cost per responder analysis of adalimumab, methotrexate and apremilast in the treatment of methotrexate-naive patients with psoriatic arthritis. Current Medical Research and Opinion, 32, 721–729.CrossRefPubMed
5.
go back to reference Brasure, M., Fuchs, E., MacDonald, R., Nelson, V. A., Koffel, E., Olson, C. M., et al. (2016). Psychological and behavioral interventions for managing insomnia disorder: An evidence report for a Clinical Practice Guideline by the American College of Physicians. Annals of Internal Medicine, 165, 113–124.CrossRefPubMed Brasure, M., Fuchs, E., MacDonald, R., Nelson, V. A., Koffel, E., Olson, C. M., et al. (2016). Psychological and behavioral interventions for managing insomnia disorder: An evidence report for a Clinical Practice Guideline by the American College of Physicians. Annals of Internal Medicine, 165, 113–124.CrossRefPubMed
6.
go back to reference Fehnel, S. E., Ervin, C. M., Carson, R. T., Rigoni, G., Lackner, J. M., Coons, S. J., et al. (2017). Development of the diary for irritable bowel syndrome symptoms to assess treatment benefit in clinical trials: Foundational Qualitative Research. Value Health, 20, 618–626.CrossRefPubMed Fehnel, S. E., Ervin, C. M., Carson, R. T., Rigoni, G., Lackner, J. M., Coons, S. J., et al. (2017). Development of the diary for irritable bowel syndrome symptoms to assess treatment benefit in clinical trials: Foundational Qualitative Research. Value Health, 20, 618–626.CrossRefPubMed
7.
go back to reference Nunley, P. D., Patel, V. V., Orndorff, D. G., Lavelle, W. F., Block, J. E., & Geisler, F. H. (2017). Superion(R) interspinous spacer treatment of moderate spinal stenosis: 4-year results. World Neurosurgery, 104, 279–289.CrossRefPubMed Nunley, P. D., Patel, V. V., Orndorff, D. G., Lavelle, W. F., Block, J. E., & Geisler, F. H. (2017). Superion(R) interspinous spacer treatment of moderate spinal stenosis: 4-year results. World Neurosurgery, 104, 279–289.CrossRefPubMed
8.
go back to reference US Department of Health and Human Services FDA Center for Drug Evaluation and Research, US Department of Health and Human Services FDA Center for Biologics Evaluation and Research, & US Department of Health and Human Services FDA Center for Devices and Radiological Health. (2006). Guidance for industry: Patient-reported outcome measures: use in medical product development to support labeling claims: Draft guidance. Health Qual Life Outcomes 4, 79. US Department of Health and Human Services FDA Center for Drug Evaluation and Research, US Department of Health and Human Services FDA Center for Biologics Evaluation and Research, & US Department of Health and Human Services FDA Center for Devices and Radiological Health. (2006). Guidance for industry: Patient-reported outcome measures: use in medical product development to support labeling claims: Draft guidance. Health Qual Life Outcomes 4, 79.
9.
go back to reference Uryniak, T. C. I., Fedorov, V. V., Jiang, Q., Oppenheimer, L., Stapinn, S., Teng, C.-H., et al. (2011). Responder analyses: A PhRMA position paper. Statistics in Biopharmaceutical Research, 3, 476–487.CrossRef Uryniak, T. C. I., Fedorov, V. V., Jiang, Q., Oppenheimer, L., Stapinn, S., Teng, C.-H., et al. (2011). Responder analyses: A PhRMA position paper. Statistics in Biopharmaceutical Research, 3, 476–487.CrossRef
10.
go back to reference Wyrwich, K. W., Bullinger, M., Aaronson, N., Hays, R. D., Patrick, D. L., & Symonds, T. (2005). Clinical Significance Consensus Meeting Group: Estimating clinically significant differences in quality of life outcomes. Quality of Life Research, 14, 285–295.CrossRefPubMed Wyrwich, K. W., Bullinger, M., Aaronson, N., Hays, R. D., Patrick, D. L., & Symonds, T. (2005). Clinical Significance Consensus Meeting Group: Estimating clinically significant differences in quality of life outcomes. Quality of Life Research, 14, 285–295.CrossRefPubMed
11.
go back to reference Coon, C. D., Cook, K. F. (2016). Telling the interpretation story: the case for strong anchors and multiple methods. In Plenary presentation at the 23rd Annual Conference of the International Society of Quality for Life Research. Coon, C. D., Cook, K. F. (2016). Telling the interpretation story: the case for strong anchors and multiple methods. In Plenary presentation at the 23rd Annual Conference of the International Society of Quality for Life Research.
12.
go back to reference Ross, M. (1989). Relation of implicit theories to the construction of personal histories. Psychological Review, 96, 341–357.CrossRef Ross, M. (1989). Relation of implicit theories to the construction of personal histories. Psychological Review, 96, 341–357.CrossRef
13.
go back to reference Schmitt, J., & Di Fabio, R. P. (2005). The validity of prospective and retrospective global change criterion measures. Archives of Physical Medicine and Rehabilitation, 86, 2270–2276.CrossRefPubMed Schmitt, J., & Di Fabio, R. P. (2005). The validity of prospective and retrospective global change criterion measures. Archives of Physical Medicine and Rehabilitation, 86, 2270–2276.CrossRefPubMed
14.
go back to reference Kamper, S. J., Ostelo, R. W., Knol, D. L., Maher, C. G., de Vet, H. C., & Hancock, M. J. (2010). Global perceived effect scales provided reliable assessments of health transition in people with musculoskeletal disorders, but ratings are strongly influenced by current status. Journal of Clinical Epidemiology, 63, 760–766.CrossRefPubMed Kamper, S. J., Ostelo, R. W., Knol, D. L., Maher, C. G., de Vet, H. C., & Hancock, M. J. (2010). Global perceived effect scales provided reliable assessments of health transition in people with musculoskeletal disorders, but ratings are strongly influenced by current status. Journal of Clinical Epidemiology, 63, 760–766.CrossRefPubMed
15.
go back to reference Metz, S. M., Wyrwich, K. W., Babu, A. N., Kroenke, K., Tierney, W. M., & Wolinsky, F. D. (2007). Validity of patient-reported health-related quality of life global ratings of change using structural equation modeling. Quality of Life Research, 16, 1193–1202.CrossRefPubMed Metz, S. M., Wyrwich, K. W., Babu, A. N., Kroenke, K., Tierney, W. M., & Wolinsky, F. D. (2007). Validity of patient-reported health-related quality of life global ratings of change using structural equation modeling. Quality of Life Research, 16, 1193–1202.CrossRefPubMed
16.
go back to reference Schwartz, C. E., Powell, V. E., & Rapkin, B. D. (2016). When global rating of change contradicts observed change: Examining appraisal processes underlying paradoxical responses over time. Quality of Life Research, 26, 847–857.CrossRefPubMed Schwartz, C. E., Powell, V. E., & Rapkin, B. D. (2016). When global rating of change contradicts observed change: Examining appraisal processes underlying paradoxical responses over time. Quality of Life Research, 26, 847–857.CrossRefPubMed
17.
go back to reference Cella, D., Lai, J. S., Nowinski, C. J., Victorson, D., Peterman, A., Miller, D., et al. (2012). Neuro-QOL: Brief measures of health-related quality of life for clinical research in neurology. Neurology, 78, 1860–1867.CrossRefPubMedPubMedCentral Cella, D., Lai, J. S., Nowinski, C. J., Victorson, D., Peterman, A., Miller, D., et al. (2012). Neuro-QOL: Brief measures of health-related quality of life for clinical research in neurology. Neurology, 78, 1860–1867.CrossRefPubMedPubMedCentral
18.
go back to reference Cella, D., Nowinski, C., Peterman, A., Victorson, D., Miller, D., Lai, J. S., et al. (2011). The neurology quality-of-life measurement initiative. Archives of Physical Medicine and Rehabilitation, 92, S28–S36.CrossRefPubMedPubMedCentral Cella, D., Nowinski, C., Peterman, A., Victorson, D., Miller, D., Lai, J. S., et al. (2011). The neurology quality-of-life measurement initiative. Archives of Physical Medicine and Rehabilitation, 92, S28–S36.CrossRefPubMedPubMedCentral
19.
go back to reference Gershon, R. C., Lai, J. S., Bode, R., Choi, S., Moy, C., Bleck, T., et al. (2012). Neuro-QOL: Quality of life item banks for adults with neurological disorders: Item development and calibrations based upon clinical and general population testing. Quality of Life Research, 21, 475–486.CrossRefPubMed Gershon, R. C., Lai, J. S., Bode, R., Choi, S., Moy, C., Bleck, T., et al. (2012). Neuro-QOL: Quality of life item banks for adults with neurological disorders: Item development and calibrations based upon clinical and general population testing. Quality of Life Research, 21, 475–486.CrossRefPubMed
21.
go back to reference HealthMeasures.net. (2016). Quality of life in neurological disorders: Scoring manual. HealthMeasures.net. (2016). Quality of life in neurological disorders: Scoring manual.
22.
go back to reference Cella, D., Choi, S., Garcia, S., Cook, K. F., Rosenbloom, S., Lai, J. S., et al. (2014). Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment. Quality of Life Research, 23, 2651–2661.CrossRefPubMedPubMedCentral Cella, D., Choi, S., Garcia, S., Cook, K. F., Rosenbloom, S., Lai, J. S., et al. (2014). Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment. Quality of Life Research, 23, 2651–2661.CrossRefPubMedPubMedCentral
23.
go back to reference Cook, K. F., Victorson, D. E., Cella, D., Schalet, B. D., & Miller, D. (2015). Creating meaningful cut-scores for Neuro-QOL measures of fatigue, physical functioning, and sleep disturbance using standard setting with patients and providers. Quality of Life Research, 24, 575–589.CrossRefPubMed Cook, K. F., Victorson, D. E., Cella, D., Schalet, B. D., & Miller, D. (2015). Creating meaningful cut-scores for Neuro-QOL measures of fatigue, physical functioning, and sleep disturbance using standard setting with patients and providers. Quality of Life Research, 24, 575–589.CrossRefPubMed
24.
go back to reference Cella, D., Hahn, E. A., & Dineen, K. (2002). Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening. Quality of Life Research, 11, 207–221.CrossRefPubMed Cella, D., Hahn, E. A., & Dineen, K. (2002). Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening. Quality of Life Research, 11, 207–221.CrossRefPubMed
Metagegevens
Titel
Idio Scale Judgment: evaluation of a new method for estimating responder thresholds
Auteurs
Karon F. Cook
Michael A. Kallen
Cheryl D. Coon
David Victorson
Deborah M. Miller
Publicatiedatum
17-06-2017
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 11/2017
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-017-1625-2

Andere artikelen Uitgave 11/2017

Quality of Life Research 11/2017 Naar de uitgave